Members of the program engage in research aimed at obtaining a mechanistic understanding of signal transduction and cellular regulation, which includes cellular signaling pathways and downstream ...

HMPL-760 is under clinical development by Hutchison MediPharma and currently in Phase I for Diffuse Large B-Cell Lymphoma.

Sovleplenib acetate is under clinical development by Hutchison MediPharma and currently in Phase I for Marginal Zone B-cell Lymphoma.

The TGF-β family of proteins plays a key role in the proliferation and differentiation of many different cell types, controlling the formation and regeneration of tissues from embryonic life to ...